Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2012 2
2013 2
2014 1
2016 3
2017 3
2020 2
2021 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean van lunen b[au] (68 results)?
Pondering plyometrics.
Ernst G, Moore J, VanLunen B, Ball D. Ernst G, et al. Among authors: vanlunen b. J Orthop Sports Phys Ther. 1997 May;25(5):350-2. J Orthop Sports Phys Ther. 1997. PMID: 9130154 No abstract available.
Changes in postural sway as a function of prolonged walking.
Thomas KS, VanLunen BL, Morrison S. Thomas KS, et al. Among authors: vanlunen bl. Eur J Appl Physiol. 2013 Feb;113(2):497-508. doi: 10.1007/s00421-012-2456-z. Epub 2012 Jul 18. Eur J Appl Physiol. 2013. PMID: 22806086
Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe.
Baraliakos X, Witte T, De Clerck L, Frediani B, Collantes-Estévez E, Katsifis G, VanLunen B, Kleine E, Hoepken B, Bauer L, Goodson N. Baraliakos X, et al. Among authors: vanlunen b. Rheumatology (Oxford). 2021 Jan 5;60(1):113-124. doi: 10.1093/rheumatology/keaa181. Rheumatology (Oxford). 2021. PMID: 32584415 Free PMC article.
Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.
Emery P, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, Heijde Dv, Vollenhoven Rv, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Emery P, et al. Among authors: vanlunen b. Ann Rheum Dis. 2016 Oct;75(10):e69. doi: 10.1136/annrheumdis-2016-210083. Epub 2016 Aug 12. Ann Rheum Dis. 2016. PMID: 27519773 Free article. No abstract available.
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW.
van der Horst-Bruinsma I, van Bentum R, Verbraak FD, Rath T, Rosenbaum JT, Misterska-Skora M, Hoepken B, Irvin-Sellers O, VanLunen B, Bauer L, Rudwaleit M. van der Horst-Bruinsma I, et al. Among authors: vanlunen b. RMD Open. 2020 Apr;6(1):e001161. doi: 10.1136/rmdopen-2019-001161. RMD Open. 2020. PMID: 32371433 Free PMC article. Clinical Trial.
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis.
Weinblatt ME, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, VanLunen B, Ecoffet C, Cioffi C, Emery P. Weinblatt ME, et al. Among authors: vanlunen b. Arthritis Rheumatol. 2017 Oct;69(10):1937-1948. doi: 10.1002/art.40196. Epub 2017 Sep 12. Arthritis Rheumatol. 2017. PMID: 28666080 Free PMC article. Clinical Trial.
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Emery P, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Emery P, et al. Among authors: vanlunen b. Ann Rheum Dis. 2017 Jan;76(1):96-104. doi: 10.1136/annrheumdis-2015-209057. Epub 2016 May 10. Ann Rheum Dis. 2017. PMID: 27165179 Free PMC article. Clinical Trial.
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension.
Keystone E, Landewé R, van Vollenhoven R, Combe B, Strand V, Mease P, Shaughnessy L, VanLunen B, van der Heijde D. Keystone E, et al. Among authors: vanlunen b. Ann Rheum Dis. 2014 Dec;73(12):2094-100. doi: 10.1136/annrheumdis-2013-203695. Epub 2013 Aug 5. Ann Rheum Dis. 2014. PMID: 23918037 Free PMC article. Clinical Trial.
12 results